Clinical Trial Update: Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and preliminary efficacy of an anticancer medication combined with immune cell therapy in patients with gastrointestinal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Anticancer medication combined with immune cell therapy (name undisclosed)

Snippet

Sponsor: Hangzhou Converd Co., Ltd. | Conditions: Gastrointestinal Cancer | Phase 1 | Status: UNKNOWN